Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 186
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Are climate change and air pollution triggering cardiovascular disease?

    Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

    How to edit any gene.

    Imagine being able to edit any geneā€”from Alzheimer's and cancer to eye color and balding. Today, that is...

    Viral Causes of Lung Cancer

    We have special access to blood specimens collected from more than 9,000 cancer free people. These individuals...

    Backer Badge Funded